Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Senescent cells are generally characterized by a reduction in proliferative capacity, adoption of a flattened and enlarged cell shape, and the appearance of senescence-associated b-galactosidase (SA-b-gal) activity (Dimri et al., 1995).”
BackgroundMethodOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“LDs of other DNA damaging agents, including various chemotherapeutic drugs and ionizing radiation (Chang et al., 1999a), and introduction of an activated ras oncogene (Serrano et al., 1997) have been reported to induce SLP in cancer cells in a similar manner.”
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237 · cited 1×
“…protein (MAP) kinases, and NF-kB are significantly activated during HD doxorubicin-induced apoptosis but not LD doxorubicin-induced cell death through mitotic catastrophe Both p38 and JNK have been implicated in apoptosis induced by various cytotoxic agents (Davis, 2000; Ono and Han, 2000).”
BackgroundGewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,285
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
Cell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269 · cited 1×
“Castedo et al. (2004) recently proposed that mitotic catastrophe results from a combination of deficient cell-cycle checkpoints and cellular damage, and that failure of cell cycle arrest before or at mitosis triggers an attempt of aberrant chromosome segregation, which culminates in activation of…”
BackgroundThe nuclear lamina is a meshwork of intermediate-type filaments
Aebi, U., Cohn, J., Buhle, L., & Gerace, L. (1986) · Nature · doi:10.1038/323560a0 · Cited by 981
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
Yan, M., Dai, T., Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J. R., & Templeton, D. J. (1994) · Nature · doi:10.1038/372798a0 · Cited by 705
Anthrazykline in der Krebstherapie: Ein Überblick
Hortobágyi, G. N. (1997) · Drugs · doi:10.2165/00003495-199700544-00003 · Cited by 678
Identification of a Human Mitotic Checkpoint Gene: hsMAD2
Li, Y., & Benezra, R. (1996) · Science · doi:10.1126/science.274.5285.246 · Cited by 598
Apoptosis: Activate NF-κB or die?
Baichwal, V. R., & Baeuerle, P. A. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00046-7 · Cited by 529
Characterization of the p53-Dependent Postmitotic Checkpoint following Spindle Disruption
Lanni, J. S., & Jacks, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1055 · Cited by 497
Chang, B.-D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., & Roninson, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203078 · Cited by 386
Chan, G. K. T., Jablonski, S. A., Sudakin, V., Hittle, J. C., & Yen, T. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.941 · Cited by 376
Dumont, P., Burton, M., Chen, Q. M., Gonos, E. S., Frippiat, C., Mazarati, J.-B., Eliaers, F., Remacle, J., & Toussaint, O. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00249-x · Cited by 375
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271
Molecular steps of death receptor and mitochondrial pathways of apoptosis
Gupta, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01404-7 · Cited by 244
p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines
Hsu, I. C., Tokiwa, T., Bennett, W., Metcalf, R. A., Welsh, J. A., Sun, T., & Harris, C. C. (1993) · Carcinogenesis · doi:10.1093/carcin/14.5.987 · Cited by 241
Seong, Y.-S., Kamijo, K., Lee, J.-S., Fernandez, E., Kuriyama, R., Miki, T., & Lee, K. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202602200 · Cited by 210
West, C. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143716 · Cited by 169
Chang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 168
Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents
Nitta, M., Kobayashi, O., Honda, S., Hirota, T., Kuninaka, S., Marumoto, T., Ushio, Y., & Saya, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207873 · Cited by 167
Characterization of cell lines established from human hepatocellular carcinoma
Park, J., Lee, J., Kang, M., Park, K., Jeon, Y., Lee, H., Kwon, H., Park, H., Yeo, K., Lee, K., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620308 · Cited by 151
Self-citationWang, Y., Blandino, G., & Givol, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202632 · Cited by 144
Gamen, S., Anel, A., Pérez‐Galán, P., Lasierra, P., Johnson, D. E., Piñeiro, A., & Naval, J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4924 · Cited by 135
Chu, K., Teele, N., Dewey, M. W., Albright, N., & Dewey, W. C. (2004) · Radiation Research · doi:10.1667/rr3221 · Cited by 120
Mantel, C., Braun, S. E., Reid, S., Henegariu, O., Liu, L., Hangoc, G., & Broxmeyer, H. E. (1999) · Blood · doi:10.1182/blood.v93.4.1390 · Cited by 120
Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients
Speth, P. A. J., Linssen, P. C. M., Boezeman, J. B. M., Wessels, H. M. C., & Haanen, C. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00262581 · Cited by 81
DNA-Dependent Protein Kinase Phosphorylation of IκBα and IκBβ Regulates NF-κB DNA Binding Properties
Liu, L., Kwak, Y.-T., Bex, F., García-Martínez, L. F., Li, X.-H., Meek, K., Lane, W. S., & Gaynor, R. B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4221 · Cited by 71
Wang, Y., Zhu, S., Cloughesy, T. F., Liau, L. M., & Mischel, P. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207244 · Cited by 71
Gene Structure and Sequence Analysis of Mouse Centromere Proteins A and C
Kalitsis, P., Macdonald, A. C., Newson, A. J., Hudson, D. F., & Choo, K. H. A. (1998) · Genomics · doi:10.1006/geno.1997.5109 · Cited by 25
Thermal stability of the cellulose synthase complex of Acetobacter xylinum
Chen, H. P., & Brown, R. M. (1999) · Cellulose · doi:10.1023/a:1009208610922 · Cited by 15
Cited by
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
Death through a tragedy: mitotic catastrophe
Vakifahmetoglu, H., Olsson, M., & Zhivotovsky, B. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.47 · Cited by 700
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
Renu, K., V.G., A., P.B., T. P., & Arunachalam, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 588
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 294
Metadata
- Authors
- Eom, Y.-W., Kim, M. A., Park, S. S., Goo, M. J., Kwon, H. J., Sohn, S., Kim, W.-H., Yoon, G., & Choi, K. S.
- Venue
- Oncogene
- Published
- 2005-05-02
- Volume
- 24
- Issue
- 30
- Pages
- 4765-4777
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1965688832
- Cited by
- 351
- References
- 36
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.